Proton pump inhibitors in cirrhosis: a retrospective five-year analysis of increased risks of hepatic decompensation and infections

PPI use in cirrhosis is linked to hepatic decompensation and higher infection risk. Judicious PPI use with clear indications is essential.

Authors

Institutions

Publication Details

Journal
New Zealand Medical Journal
Published
2025-04-30
DOI
https://doi.org/10.26635/6965.6838
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Proton pump inhibitors in cirrhosis: a retrospective five-year analysis of increased risks of hepatic decompensation and infections

Abhimati Ravikulan, Christin Coomarasamy, Ashok Raj, NH Russell
New Zealand Medical Journal
Liver Disease and Transplantation
article

Proton pump inhibitors in cirrhosis: a retrospective five-year analysis of increased risks of hepatic decompensation and infections

Abhimati Ravikulan, Christin Coomarasamy, Ashok Raj, NH Russell
article en

Abstract

PPI use in cirrhosis is linked to hepatic decompensation and higher infection risk. Judicious PPI use with clear indications is essential.

New Zealand Medical JournalVol. 138(1614)
The Royal Melbourne Hospital (AU), Counties Manukau District Health Board (NZ)
Openalex Percentile: Top 89%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.